CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Relay Therapeutics, Inc. - RLAY CFD

2.45
0.41%
Market Trading Hours* (UTC) Opens on Thursday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023624 %
Charges from full value of position ($-4.49)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023624%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001401 %
Charges from full value of position ($0.27)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001401%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 2.44
Open 2.38
1-Year Change -70.18%
Day's Range 2.38 - 2.5
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 1, 2025 2.44 -0.06 -2.40% 2.50 2.51 2.34
Mar 31, 2025 2.58 0.00 0.00% 2.58 2.67 2.42
Mar 28, 2025 2.68 -0.21 -7.27% 2.89 2.93 2.66
Mar 27, 2025 2.96 0.19 6.86% 2.77 3.04 2.77
Mar 26, 2025 2.82 -0.14 -4.73% 2.96 2.98 2.82
Mar 25, 2025 2.93 -0.13 -4.25% 3.06 3.06 2.88
Mar 24, 2025 3.06 0.00 0.00% 3.06 3.12 3.03
Mar 21, 2025 3.03 -0.03 -0.98% 3.06 3.15 3.01
Mar 20, 2025 3.22 0.04 1.26% 3.18 3.34 3.18
Mar 19, 2025 3.32 0.18 5.73% 3.14 3.32 3.12
Mar 18, 2025 3.26 -0.13 -3.83% 3.39 3.39 3.16
Mar 17, 2025 3.48 0.03 0.87% 3.45 3.61 3.36
Mar 14, 2025 3.61 0.30 9.06% 3.31 3.63 3.28
Mar 13, 2025 3.38 -0.16 -4.52% 3.54 3.86 3.20
Mar 12, 2025 3.63 0.23 6.76% 3.40 3.63 3.35
Mar 11, 2025 3.43 0.31 9.94% 3.12 3.44 3.06
Mar 10, 2025 3.24 -0.05 -1.52% 3.29 3.39 3.16
Mar 7, 2025 3.42 0.04 1.18% 3.38 3.49 3.30
Mar 6, 2025 3.46 0.21 6.46% 3.25 3.50 3.19
Mar 5, 2025 3.38 0.19 5.96% 3.19 3.38 3.08

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Relay Therapeutics, Inc. Company profile

About Relay Therapeutics Inc

Relay Therapeutics Inc. is a clinical-stage precision medicines company. The Company is focused on transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The Company is advancing a pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008, RLY-2608 and RLY-1971. Its RLY-1971 binds and stabilizes Src homology region two (SH2)-containing protein tyrosine phosphatase two (SHP2) in its inactive conformation. Its RLY-4008, is it inhibitor of fibroblast growth factor receptor 2 (FGFR2), enriched for patients with advanced solid tumors having oncogenic FGFR2. The Company uses its Dynamo platform to focus on precision oncology. It is also advancing several early programs focused on other precision oncology and genetic disease targets.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Relay Therapeutics Inc revenues decreased 96% to $3M. Net loss applicable to common stockholders increased 58% to $363.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects General and ad increase of 60% to $33M (expense), Stock-based Compensation in R&D increase of 70% to $24.9M (expense).

Industry: Biotechnology & Medical Research (NEC)

399 Binney Street
2nd Floor
CAMBRIDGE
MASSACHUSETTS 02139
US

People also watch

US100

18,687.30 Price
-3.680% 1D Chg, %
Long position overnight fee -0.0236%
Short position overnight fee 0.0014%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

1,795.78 Price
-6.200% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

XRP/USD

2.04 Price
-5.460% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01016

BTC/USD

82,527.25 Price
-3.230% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading